iotrolan has been researched along with Dementia, Vascular in 1 studies
iotrolan: nonionic, isotonic contrast medium designed for intrathecal use; RN given refers to cpd without isomeric designation; DL-3-117 refers to stereoisomer; structure given in first source
Dementia, Vascular: An imprecise term referring to dementia associated with CEREBROVASCULAR DISORDERS, including CEREBRAL INFARCTION (single or multiple), and conditions associated with chronic BRAIN ISCHEMIA. Diffuse, cortical, and subcortical subtypes have been described. (From Gerontol Geriatr 1998 Feb;31(1):36-44)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kono, K | 1 |
Sugita, Y | 1 |
Funaki, C | 1 |
Kuzuya, M | 1 |
Hayashi, T | 1 |
Yamada, K | 1 |
Tajima, T | 1 |
Suzuki, Y | 1 |
Iguchi, A | 1 |
Yamamoto, T | 1 |
1 other study available for iotrolan and Dementia, Vascular
Article | Year |
---|---|
[Occult CSF flow disturbance of patients with Alzheimer type dementia and vascular dementia--results from iotrolan CT-cisternography].
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Dementia, Vascular; Female; Humans; Hydrocephalus, Norma | 1994 |